Stage III (unresectable)
Showing 26 - 50 of >10,000
Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC
Active, not recruiting
- Metastatic Carcinoma in the Adrenal Cortex
- +3 more
- Cabozantinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 12, 2022
NSCLC (NSCLC) Trial in Worldwide (Durvalumab)
Active, not recruiting
- Non-small Cell Lung Cancer (NSCLC)
-
Gainesville, Georgia
- +27 more
Dec 20, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +20 more
- Ipilimumab
- +3 more
-
Tampa, Florida
- +6 more
Jan 13, 2023
Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma
Completed
- Stage III Hepatocellular Carcinoma AJCC v8
- +6 more
- Yttrium Y 90 Glass Microspheres
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
NSCLC Stage III Trial in Hefei (Envafolimab)
Not yet recruiting
- Non-small Cell Lung Cancer Stage III
-
Hefei, Anhui, ChinaAnhui Provincial Cancer Hospital
Jun 8, 2022
Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically
Recruiting
- Nonsmall Cell Lung Cancer
- +3 more
- Genomically Guided Radiation Therapy (RT)
-
Tampa, FloridaMoffitt Cancer Center
May 23, 2023
NSCLC Stage III, EGFR Positive NSCLC, Non-squamous Non-small-cell Lung Cancer Trial in Korea, Republic of (Lazertinib)
Recruiting
- Non-small Cell Lung Cancer Stage III
- +2 more
-
Busan, Korea, Republic of
- +12 more
Jan 17, 2023
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Rigosertib
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Feb 28, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +12 more
- Biopsy
- +8 more
- (no location specified)
Jun 8, 2023
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes
Recruiting
- Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)
-
Grozny, Russian Federation
- +4 more
May 31, 2023
NSCLC, Stage III Trial in Chengdu (GFH018, Toripalimab, Paclitaxel)
Not yet recruiting
- NSCLC, Stage III
- GFH018
- +6 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
May 23, 2022
Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)
Recruiting
- Stage III Non-small-cell Lung Cancer
- Neoadjuvant therapy
- +4 more
-
Foshan, Guangdong, China
- +2 more
Oct 25, 2022
Metastatic Melanoma Trial in Boston (Tremelimumab, MEDI3617)
Active, not recruiting
- Metastatic Melanoma
-
Boston, Massachusetts
- +1 more
Mar 22, 2022
Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,
Active, not recruiting
- Metastatic Malignant Neoplasm in the Brain
- +7 more
- Binimetinib
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Active, not recruiting
- Stage III Cutaneous Melanoma AJCC v7
- +4 more
- Cryosurgery
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jan 3, 2023
Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8, Stage IV Penile Cancer AJCC v8 Trial in Phoenix,
Not yet recruiting
- Metastatic Penile Squamous Cell Carcinoma
- +3 more
- Enfortumab Vedotin
-
Phoenix, Arizona
- +2 more
Oct 23, 2023
NSCLC Trial in Jinan (Anlotinib HCl capsule Combined With Concurrent Chemoradiotherapy)
Terminated
- Non-small Cell Lung Cancer
- Anlotinib hydrochloride capsule Combined With Concurrent Chemoradiotherapy
-
Jinan, Shandong, ChinaShandong Cancer Hospital
Feb 9, 2022
Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)
Not yet recruiting
- Stage III Non-small Cell Lung Cancer
- +2 more
- standard Radiotherapy
- +3 more
- (no location specified)
Oct 20, 2023
Lung Cancer, Stage III Lung Cancer, Unresectable Lung Carcinoma Trial in Barcelona (procedure, diagnostic test, drug)
Recruiting
- Lung Cancer
- +2 more
- Sample collection
- +3 more
-
Barcelona, SpainParc de Salut Mar - Hospital del Mar
Dec 8, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester
Recruiting
- Advanced Pancreatic Carcinoma
- +9 more
- Endoscopic Ultrasound
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 13, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +3 more
- Ipilimumab
- Nivolumab
-
Rochester, MinnesotaMayo Clinic in Rochester
May 6, 2022